Asia Pacific Molecular Diagnostics Market Forecast to 2030 – Regional Analysis – by Disease Area (Oncology, Infectious Disease, Genetic Testing, Cardiac Diseases, Immune System Disorders, and Others), Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization, and Others), Product and Services (Assays & Kits, Instruments, and Services & Software), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and Others)

TIPRE00026008 | Pages: 167 | Medical Device | Jan 2024 | Type: Regional | Status: Published

The Asia Pacific molecular diagnostics market is expected to grow from US$ 3,478.48 million in 2022 to US$ 9,698.11 million by 2030. It is estimated to grow at a CAGR of 13.7% from 2022 to 2030.

Advancements in Molecular Diagnostics Technologies Fuels Asia Pacific Molecular Diagnostics Market

Molecular diagnostic techniques and platforms are being used in all areas of anatomic and clinical pathologies. DNA or RNA sequences that are associated with disease, including single nucleotide polymorphism, deletions, rearrangements, and insertions, can be detected in molecular diagnostic tests. Molecular diagnosis has undergone further improvements after the emergence of COVID-19. Conventionally, CT scans, hematological tests, and RT-PCR were in use for testing. As COVID-19 cases grew rapidly in 2020, the need for rapid, precise testing platforms surged to overcome the disadvantages of conventional testing. Computed tomography (CT), a cost-intensive procedure that may not be available in all hospitals, fails to detect viral infections and other diseases in asymptomatic patients. RT-PCR, which was widely used, was also time-consuming and expensive, and was unable to detect a low viral load during the early stages of infection. Consequently, researchers developed novel approaches to detect SARS-CoV-2, which were faster and more cost effective. Reverse transcription loop-mediated isothermal amplification (RT-LAMP), microarray-based detection, aptamer-based diagnosis, SHERLOCK, SHERLOCKv2, FET Biosensors, cell-based potentiometric diagnosis, and molecular imprinting technology are a few of the examples of novel molecular diagnostics techniques developed for COVID-19 diagnosis. In the last few years, FDA reports have indicated that advancements in molecular testing, antigen-dependent testing, and serological testing have been approved. Collaborative efforts by scientific communities in different countries to manage the COVID-19 pandemic and reduce the extent of mortality have benefited the overall molecular tools and diagnosis landscape, which is likely to create significant opportunities for the molecular diagnostics market in the future.

Asia Pacific Molecular Diagnostics Market Overview

Asia Pacific includes Malaysia, Thailand, India, Singapore, the Philippines, Vietnam, Indonesia, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. Rising geriatric population, increasing cancer cases, growing technological advancements, and increasing number of startups, biotechnology, and biopharmaceutical companies are driving the molecular diagnostics market in this region. Moreover, the rise in research activities in the region and the presence of associations or organizations enhancing the quality of care in cancer contribute to the molecular diagnostics market growth.

Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Molecular Diagnostics Market Segmentation

The Asia Pacific molecular diagnostics market is segmented into disease area, technology, product and services, end user, and country.

Based on disease area, the Asia Pacific molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment registered the largest Asia Pacific molecular diagnostics market share in 2022.

Based on technology, the Asia Pacific molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment registered the largest Asia Pacific molecular diagnostics market share in 2022. The polymerase chain reaction (PCR) is further sub segmented into RT-PCR, qPCR, multiplex PCR, and others.

Based on product and services, the Asia Pacific molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment registered the largest Asia Pacific molecular diagnostics market share in 2022.

Based on end users, the Asia Pacific molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held the largest Asia Pacific molecular diagnostics market share in 2022.

Based on country, the Asia Pacific molecular diagnostics market has been categorized into India, Singapore, Malaysia, Philippines, Thailand, Indonesia, Vietnam, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific molecular diagnostics market in 2022.  

Abbott Laboratories, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, bioMerieux SA, Illumina Inc, Danaher, Siemens Healthineers AG, Novartis AG, and TBG Diagnostics Limited are some of the leading companies operating in the Asia Pacific molecular diagnostics market.    

1.           Introduction

1.1       The Insight Partners Research Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.           Asia Pacific Molecular Diagnostics Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1         Asia Pacific PEST Analysis

5.           Asia Pacific Molecular Diagnostics Market - Key Industry Dynamics

5.1       Key Market Drivers:

5.1.1         Development of New Products and Increase in Demand for Point-of-Care Testing

5.1.2         Surging Prevalence of Associated Diseases

5.2       Market Restraints

5.2.1         Limitations Associated with Molecular Testing

5.3       Market Opportunities

5.3.1         Advancements in Molecular Diagnostics Technologies

5.4       Future Trends

5.4.1         Molecular Diagnostics in Personalized Medicine

5.5       Impact Analysis:

6.           Molecular Diagnostics Market - Asia Pacific Market Analysis

6.1       Asia Pacific Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030

7.           Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Disease Area

7.1       Overview

7.2       Asia Pacific Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)

7.3       Oncology

7.3.1         Overview

7.3.2         Oncology: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.4       Infectious Disease

7.4.1         Overview

7.4.2         Infectious Disease: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.5       Genetic Testing

7.5.1         Overview

7.5.2         Genetic Testing: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.6       Cardiac Diseases

7.6.1         Overview

7.6.2         Cardiac Diseases: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.7       Immune System Disorders

7.7.1         Overview

7.7.2         Immune System Disorders: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.8       Others

7.8.1         Overview

7.8.2         Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.           Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Technology

8.1       Overview

8.2       Asia Pacific Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)

8.3       Polymerase Chain Reaction

8.3.1         Overview

8.3.2         PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.3.2.1            RT-PCR

8.3.2.1.1           Overview

8.3.3         RT-PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.3.3.1            qPCR

8.3.3.1.1           Overview

8.3.4         PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.3.4.1            Multiplex PCR

8.3.4.1.1           Overview

8.3.5         Multiplex PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.3.5.1            Others

8.3.5.1.1           Overview

8.3.6         Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.4       Isothermal Nucleic Acid Amplification Technology (INAAT)

8.4.1         Overview

8.4.2         Isothermal Nucleic Acid Amplification Technology (INAAT): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.5       DNA Sequencing and Next-Generation Sequencing (NGS)

8.5.1         Overview

8.5.2         DNA Sequencing and Next-Generation Sequencing (NGS): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.6       DNA Microarrays

8.6.1         Overview

8.6.2         DNA Microarrays: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.7       In-Situ Hybridization (ISH)

8.7.1         Overview

8.7.2         In-Situ Hybridization (ISH): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.8       Others

8.8.1         Overview

8.8.2         Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.           Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Product and Services

9.1       Overview

9.2       Asia Pacific Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)

9.3       Assays and Kits

9.3.1         Overview

9.3.2         Assays and Kits: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.4       Instruments

9.4.1         Overview

9.4.2         Instruments: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.5       Services and Software

9.5.1         Overview

9.5.2         Services and Software: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.        Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 – by End User

10.1     Overview

10.2     Asia Pacific Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)

10.3     Hospitals and Clinics

10.3.1       Overview

10.3.2       Hospitals and Clinics: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.4     Diagnostics Laboratories

10.4.1       Overview

10.4.2       Diagnostics Laboratories: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.5     Research and Academic Institutes

10.5.1       Overview

10.5.2       Research and Academic Institutes: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030  (US$ Million)

10.6     Others

10.6.1       Overview

10.6.2       Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

11.        Asia Pacific Molecular Diagnostics Market - Country Analysis

11.1     Asia Pacific Molecular Diagnostics Market, Revenue and Forecast to 2030

11.1.1       Overview

11.1.1.1          Asia Pacific Molecular Diagnostics Market by Country

11.1.2       China

11.1.2.1          Overview

11.1.3       China: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.4       China: Molecular Diagnostics Market, by Disease Area

11.1.5       China: Molecular Diagnostics Market, by Technology

11.1.5.1          China: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.6       China:Molecular Diagnostics Market, by Product and Services

11.1.7       China: Molecular Diagnostics Market, by End User

11.1.8       Japan

11.1.8.1          Overview

11.1.9       Japan:  Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.10    Japan:   Molecular Diagnostics Market, by Disease Area

11.1.11    Japan:   Molecular Diagnostics Market, by Technology

11.1.11.1       Japan:   Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.12    Japan:   Molecular Diagnostics Market, by Product and Services

11.1.13    Japan:   Molecular Diagnostics Market, by End User

11.1.14    India

11.1.14.1       Overview

11.1.15    India: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.16    India:  Molecular Diagnostics Market, by Disease Area

11.1.17    India: Molecular Diagnostics Market, by Technology

11.1.17.1       India: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.18    India: Molecular Diagnostics Market, by Product and Services

11.1.19    India:  Molecular Diagnostics Market, by End User

11.1.20    Australia

11.1.20.1       Overview

11.1.21    Australia:  Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.22    Australia:   Molecular Diagnostics Market, by Disease Area

11.1.23    Australia:  Molecular Diagnostics Market, by Technology

11.1.23.1       Australia:   Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.24    Australia:   Molecular Diagnostics Market, by Product and Services

11.1.25    Australia:   Molecular Diagnostics Market, by End User

11.1.26    South Korea

11.1.26.1       Overview

11.1.27    South Korea:  Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.28    South Korea:  Molecular Diagnostics Market, by Disease Area

11.1.29    South Korea:  Molecular Diagnostics Market, by Technology

11.1.29.1       South Korea:  Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.30    South Korea:  Molecular Diagnostics Market, by Product and Services

11.1.31    South Korea:  Molecular Diagnostics Market, by End User

11.1.32    Singapore

11.1.32.1       Overview

11.1.33    Singapore:  Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.34    Singapore:  Molecular Diagnostics Market, by Disease Area

11.1.35    Singapore:  Molecular Diagnostics Market, by Technology

11.1.35.1       Singapore:  Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.36    Singapore: Molecular Diagnostics Market, by Product and Services

11.1.37    Singapore:  Molecular Diagnostics Market, by End User

11.1.38    Malaysia

11.1.38.1       Overview

11.1.39    Malaysia:  Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.40    Malaysia: Molecular Diagnostics Market, by Disease Area

11.1.41    Malaysia:  Molecular Diagnostics Market, by Technology

11.1.41.1       Malaysia:  Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.42    Malaysia:  Molecular Diagnostics Market, by Product and Services

11.1.43    Malaysia:  Molecular Diagnostics Market, by End User

11.1.44    Philippines

11.1.44.1       Overview

11.1.45    Philippines: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.46    Philippines:  Molecular Diagnostics Market, by Disease Area

11.1.47    Philippines:  Molecular Diagnostics Market, by Technology

11.1.47.1       Philippines:  Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.48    Philippines: Molecular Diagnostics Market, by Product and Services

11.1.49    Philippines:  Molecular Diagnostics Market, by End User

11.1.50    Thailand

11.1.50.1       Overview

11.1.51    Thailand:  Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.52    Thailand: Molecular Diagnostics Market, by Disease Area

11.1.53    Thailand: Molecular Diagnostics Market, by Technology

11.1.53.1       Thailand: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.54    Thailand: Molecular Diagnostics Market, by Product and Services

11.1.55    Thailand:  Molecular Diagnostics Market, by End User

11.1.56    Indonesia

11.1.56.1       Overview

11.1.57    Indonesia: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.58    Indonesia:   Molecular Diagnostics Market, by Disease Area

11.1.59    Indonesia:  Molecular Diagnostics Market, by Technology

11.1.59.1       Indonesia:   Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.60    Indonesia:   Molecular Diagnostics Market, by Product and Services

11.1.61    Indonesia:   Molecular Diagnostics Market, by End User

11.1.62    Vietnam

11.1.62.1       Overview

11.1.63    Vietnam:  Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.64    Vietnam:  Molecular Diagnostics Market, by Disease Area

11.1.65    Vietnam:   Molecular Diagnostics Market, by Technology

11.1.65.1       Vietnam:  Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.66    Vietnam:  Molecular Diagnostics Market, by Product and Services

11.1.67    Vietnam:  Molecular Diagnostics Market, by End User

11.1.68    Rest of Asia Pacific

11.1.68.1       Overview

11.1.69    Rest of Asia Pacific:  Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.70    Rest of Asia Pacific:  Molecular Diagnostics Market, by Disease Area

11.1.71    Rest of Asia Pacific:  Molecular Diagnostics Market, by Technology

11.1.71.1       Rest of Asia Pacific:  Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.72    Rest of Asia Pacific:  Molecular Diagnostics Market, by Product and Services

11.1.73    Rest of Asia Pacific:  Molecular Diagnostics Market, by End User

12.        Asia Pacific Molecular Diagnostics Market Industry Landscape

12.1     Overview

12.2     Growth Strategies Done by the Companies in the Market (%)

12.3     Organic Developments

12.3.1       Overview

12.4     Inorganic Developments

12.4.1       Overview

13.        Asia Pacific Molecular Diagnostics Market, Key Company Profiles

13.1     Abbott Laboratories

13.1.1       Key Facts

13.1.2       Business Description

13.1.3       Products and Services

13.1.4       Financial Overview

13.1.5       SWOT Analysis

13.1.6       Key Developments

13.2     Agilent Technologies Inc

13.2.1       Key Facts

13.2.2       Business Description

13.2.3       Products and Services

13.2.4       Financial Overview

13.2.5       SWOT Analysis

13.2.6       Key Developments

13.3     Thermo Fisher Scientific Inc

13.3.1       Key Facts

13.3.2       Business Description

13.3.3       Products and Services

13.3.4       Financial Overview

13.3.5       SWOT Analysis

13.3.6       Key Developments

13.4     F. Hoffmann-La Roche Ltd

13.4.1       Key Facts

13.4.2       Business Description

13.4.3       Products and Services

13.4.4       Financial Overview

13.4.5       SWOT Analysis

13.4.6       Key Developments

13.5     Qiagen NV

13.5.1       Key Facts

13.5.2       Business Description

13.5.3       Products and Services

13.5.4       Financial Overview

13.5.5       SWOT Analysis

13.5.6       Key Developments

13.6     bioMerieux SA

13.6.1       Key Facts

13.6.2       Business Description

13.6.3       Products and Services

13.6.4       Financial Overview

13.6.5       SWOT Analysis

13.6.6       Key Developments

13.7     Illumina Inc

13.7.1       Key Facts

13.7.2       Business Description

13.7.3       Products and Services

13.7.4       Financial Overview

13.7.5       SWOT Analysis

13.7.6       Key Developments

13.8     Danaher

13.8.1       Key Facts

13.8.2       Business Description

13.8.3       Products and Services

13.8.4       Financial Overview

13.8.5       SWOT Analysis

13.8.6       Key Developments

13.9     Siemens Healthineers AG

13.9.1       Key Facts

13.9.2       Business Description

13.9.3       Products and Services

13.9.4       Financial Overview

13.9.5       SWOT Analysis

13.9.6       Key Developments

13.10  Novartis AG

13.10.1    Key Facts

13.10.2    Business Description

13.10.3    Products and Services

13.10.4    Financial Overview

13.10.5    SWOT Analysis

13.10.6    Key Developments

13.11  TBG Diagnostics Limited

13.11.1    Key Facts

13.11.2    Business Description

13.11.3    Products and Services

13.11.4    Financial Overview

13.11.5    SWOT Analysis

13.11.6    Key Developments

14.        Appendix

14.1     About Us

14.2     Glossary of Terms

 

 

 

LIST OF TABLES

Table 1.             Asia Pacific Molecular Diagnostics Market Segmentation

Table 2.             China: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area

Table 3.             China:Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 4.             China: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 5.             China:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 6.             China: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 7.             Japan:  Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – Disease Area

Table 8.             Japan:  Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) – Technology

Table 9.             Japan:   Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 10.          Japan:   Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) – Product and Services

Table 11.          Japan:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 12.          India:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area

Table 13.          India: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 14.          India:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 15.          India: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 16.          India: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 17.          Australia:   Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area

Table 18.          Australia:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 19.          Australia:   Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 20.          Australia:   Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 21.          Australia:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 22.          South Korea:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area

Table 23.          South Korea:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 24.          South Korea:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 25.          South Korea:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 26.          South Korea:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 27.          Singapore:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area

Table 28.          Singapore:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 29.          Singapore: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 30.          Singapore:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 31.          Singapore:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – End User

Table 32.          Malaysia:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area

Table 33.          Malaysia:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 34.          Malaysia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 35.          Malaysia:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 36.          Malaysia:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 37.          Philippines: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area

Table 38.          Philippines:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 39.          Philippines: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 40.          Philippines:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 41.          Philippines:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 42.          Thailand:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area

Table 43.          Thailand: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 44.          Thailand: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 45.          Thailand:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 46.          Thailand: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 47.          Indonesia:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area

Table 48.          Indonesia:   Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 49.          Indonesia:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 50.          Indonesia:   Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 51.          Indonesia:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 52.          Vietnam:   Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area

Table 53.          Vietnam:   Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 54.          Vietnam:   Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 55.          Vietnam:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 56.          Vietnam:   Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 57.          Rest of Asia Pacific:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area

Table 58.          Rest of Asia Pacific:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 59.          Rest of Asia Pacific:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 60.          Rest of Asia Pacific:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 61.          Rest of Asia Pacific:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 62.          Organic Developments Done By Companies

Table 63.          Inorganic Developments Done By Companies

Table 64.          Glossary of Terms, Molecular Diagnostics Market

 

 

LIST OF FIGURES

Figure 1.           Asia Pacific - PEST Analysis

Figure 2.           Asia Pacific Molecular Diagnostics Market - Key Industry Dynamics

Figure 3.           Impact Analysis of Drivers and Restraints

Figure 4.           Asia Pacific Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030

Figure 5.           Asia Pacific Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)

Figure 6.           Oncology: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 7.           Infectious Disease: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 8.           Genetic Testing: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 9.           Cardiac Diseases: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 10.        Immune System Disorders: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 11.        Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 12.        Asia Pacific Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)

Figure 13.        PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 14.        RT-PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 15.        qPCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 16.        Multiplex PCR: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 17.        Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 18.        Isothermal Nucleic Acid Amplification Technology (INAAT): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 19.        DNA Sequencing and Next-Generation Sequencing (NGS): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 20.        DNA microarrays: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 21.        In-Situ Hybridization (ISH): Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 22.        Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 23.        Asia Pacific Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)

Figure 24.        Assays and Kits: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 25.        Instruments: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 26.        Services and Software: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 27.        Asia Pacific Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)

Figure 28.        Hospitals and Clinics: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 29.        Ambulatory Surgical Centers: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 30.        Research and Academic Institutes: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 31.        Others: Asia Pacific Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 32.        Asia Pacific Molecular Diagnostics Market, By Country, 2022 (US$ Mn)

Figure 33.        Asia Pacific Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)

Figure 34.        China: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 35.        Japan:  Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

Figure 36.        India: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 37.        Australia:   Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 38.        South Korea:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 39.        Singapore:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 40.        Malaysia:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 41.        Philippines:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 42.        Thailand: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 43.        Indonesia:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 44.        Vietnam:   Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 45.        Rest of Asia Pacific:   Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 46.        Growth Strategies Done by the Companies in the Market (%)

 

  1. Abbott Laboratories
  2. Agilent Technologies Inc
  3. bioMerieux SA
  4. Danaher
  5. F. Hoffmann-La Roche Ltd
  6. Illumina Inc
  7. Novartis AG
  8. Qiagen NV
  9. Siemens Healthineers AG
  10. TBG Diagnostics Limited
  11. Thermo Fisher Scientific Inc
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific Molecular Diagnostic market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific Molecular Diagnostic market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the molecular diagnostics market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

 

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440